In vivo degradation of calcium phosphate cement incorporated into biodegradable microspheres

Acta Biomaterialia

Volumn 6, Issue 6, 2010, Pages 2200-2211

  Habraken, W J E M ^a   Liao, H B ^a,b   Zhang, Z ^c   Wolke, J G C ^a   Grijpma, D W ^c,d   Mikos, A G ^e   Feijen, J ^c   Jansen, J A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c Faculty of Science and Technology   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e Rice University   (United States)

Author keywords

Animal model; Biodegradation; Calcium phosphate cement; In vitro; Microspheres

Indexed keywords

CALCIUM PHOSPHATE; CEMENTS; EROSION; MICROSPHERES; TISSUE;

ANIMAL MODEL; BIODEGRADABLE MICROSPHERES; CALCIUM PHOSPHATE CEMENT; CEMENT COMPOSITE; IN-VITRO; IN-VIVO; POLY (TRIMETHYLENE CARBONATE); POLYTRIMETHYLENE CARBONATE; TISSUE RESPONSE; VIVO DEGRADATION;

BIODEGRADATION;

CALCIUM PHOSPHATE; CEMENT; GELATIN; MICROSPHERE; POLY(LACTIC CO GLYCOLIC ACID); POLY(TRIMETHYLENE CARBONATE); POLYMER; UNCLASSIFIED DRUG; BIOMATERIAL; BONE CEMENT; TISSUE SCAFFOLD;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; DEGRADATION KINETICS; FEMALE; HISTOLOGY; MOLECULAR WEIGHT; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOFT TISSUE; X RAY DIFFRACTION; ANIMAL; BIODEGRADABLE IMPLANT; CHEMISTRY; EQUIPMENT; MATERIALS TESTING; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ABSORBABLE IMPLANTS; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE CEMENTS; EQUIPMENT FAILURE ANALYSIS; FEMALE; MATERIALS TESTING; MICROSPHERES; RABBITS; TISSUE SCAFFOLDS;

EID: 77956640528     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.12.028     Document Type: Article

References (34)

1. Ooms EM, Wolke JCC, van der Waerden JP, Jansen JA. Trabecular bone response to injectable calcium phosphate (Ca-P) cement. J Biomed Mater Res A 2002;61(1):9-18.
2. Theiss F, Apelt D, Brand B, Kutter A, Zlinsky K, Bohner M, et al. Biocompatibility and resorption of a brushite calcium phosphate cement. Biomaterials 2005;26(21):4383-94.
3. Kuemmerle JM, Oberle A, Oechslin C, Bohner M, Frei C, Boecken I, et al. Assessment of the suitability of a new brushite calcium phosphate cement for cranioplasty-an experimental study in sheep. J Craniomaxillofac Surg 2005;33(1):37-44.
4. Habraken WJEM, Wolke JGC, Jansen JA. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59(4/5): 234-45.
5. Del Real RP, Ooms EM, Wolke JGC, Vallet-Regí M, Jansen JA. In vivo bone response to porous calcium phosphate cement. J Biomed Mater Res A 2003;65(1):30-6.
6. Del Real RP, Wolke JGC, Vallet-Regí M, Jansen JA. A new method to produce macropores in calcium phosphate cements. Biomaterials 2002;23(17):3673-80.
7. Ginebra MP, Delgado JA, Harr I, Almirall A, Del Valle S, Planell JA. Factors affecting the structure and properties of an injectable self-setting calcium phosphate foam. J Biomed Mater Res A 2007;80(2):352-61.
8. Xu HH, Weir MD, Burguera EF, Fraser AM. Injectable and macroporous calcium phosphate cement scaffold. Biomaterials 2006;27(24):4279-87.
9. Simon Jr CG, Khatri CA, Wight SA, Wang FW. Preliminary report on the biocompatibility of a moldable, resorbable, composite bone graft consisting of calcium phosphate cement and poly (lactide-co-glycolide) microspheres. J Orthop Res 2002;20(3):473-82.
10. Ruhé PQ, Hedberg EL, Torio Padron N, Spauwen PHM, Jansen JA, Mikos AG. rhBMP-2 release from injectable poly (D, L-lactic-co-glycolic acid)/calcium phosphate cement composites. J Bone Joint Surg 2003;85 A (3):75-81.
11. Schnieders J, Gbureck U, Thull R, Kissel T. Controlled release of gentamycin from calcium phosphate-poly (lactic acid-co-glycolic acid) composite bone cement. Biomaterials 2006;27(23):4239-49.
12. Habraken WJEM, Wolke JGC, Mikos AG, Jansen JA. Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J Biomater Sci Polym Ed 2006;17(9):1057-74.
13. Habraken WJEM, de Jonge LT, Wolke JGC, Yubao L, Mikos AG, Jansen JA. Introduction of gelatin microspheres into an injectable calcium phosphate cement. J Biomed Mater Res A 2008;87(3):643-55.
14. Habraken WJEM, Zhang Z, Wolke JGC, Grijpma DW, Mikos AG, Feijen J, et al. Introduction of enzymatically degradable poly (trimethylene carbonate) microspheres into an injectable calcium phosphate cement. Biomaterials 2008;29(16):2464-76.
15. Habraken WJEM, Wolke JGC, Mikos AG, Jansen JA. Porcine gelatin microsphere/calcium phosphate cement composites: in vitro degradation and drug release. J Biomed Mater Res B Appl Biomater 2009;91 B (2):555-61.
16. Holland TA, Mikos AG. Advances in drug delivery for articular cartilage. J Control Release 2003;86(1):1-14.
17. Zhang Z, Kuijer R, Bulstra SK, Grijpma DW, Feijen J. The in vivo and in vitro behavior of poly (trimethylene carbonate). Biomaterials 2006;27(9):1741-8.
18. Lu L, Stamatas GN, Mikos AG. Controlled release of transforming growth factor β1 from biodegradable polymer microparticles. J Biomed Mater Res A 2000;50:440-51.
19. Holland TA, Tessmar JK, Tabata Y, Mikos AG. Transforming growth factor-β1 release from oligo (poly (ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J Control Release 2004;94(1):101-14.
20. Zhang Z, Foks MA, Grijpma DW, Feijen J. PTMC and MPEG-PTMC microparticles for hydrophilic drug delivery. J Control Release 2005;101(1-3): 392-4.
21. Schwach G, Oudry N, Delhomme S, Luck M, Lindner H, Gurny R. Biodegradable microparticles for sustained release of a new GnRH antagonist. Part I. Screening commercial PLGA and formulation technologies. Eur J Pharm Biopharm 2003;56:327.
22. Klein JP, Sauren YM, Modderman WE, van der Waerden JP. A new saw technique improves preparation of bone sections for light and electron microscopy. J Appl Biomater 1994;5:369-73.
23. Schwartz K, Epple M. A detailed characterization of polyglycolide prepared by solid-state polycondensation reaction. Macromol Chem Phys 1999;200(10):2221-9.
24. Péré E, Cardy H, Cairon O, Simon M, Lacombe S. Quantitative assessment of organic compounds adsorbed on silica gel by FTIR and UV-VIS spectroscopies: the contribution of diffuse reflectance spectroscopy. Vib Spectrosc 2001;25:163-75.
25. Jansen JA, Dhert WJ, van der Waerden JP, von Recum AF. Semi-quantitative and qualitative histologic analysis method for the evaluation of implant biocompatibility. J Invest Surg 1994;7:123-34.
26. Pouchert CJ, editor. The Aldrich library of infrared spectra. 3rd ed. St. Louis, MO: Sigma-Aldrich; 1981. p. 435.
27. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005;26:5474-91.
28. Link DP, van den Dolder J, Jurgens WJ, Wolke JG, Jansen JA. Mechanical evaluation of implanted calcium phosphate cement incorporated with PLGA microparticles. Biomaterials 2006;27(28):4941-7.
29. Le Huec JC, Schaeverbeke T, Clement D, Faber J, Le Rebeller A. Influence of porosity on the mechanical resistance of hydroxyapatite ceramics under compressive stress. Biomaterials 1995;16:113-8.
30. Itala AI, Ylanen HO, Ekholm C, Karlsson KH, Aro HT. Pore diameter of more than 100 mm is not requisite for bone ingrowth in rabbits. J Biomed Mater Res 2001;58:679-83.
31. Bohner M, Baumgart F. Theoretical model to determine the effects of geometrical factors on the resorption of calcium phosphate bone substitutes. Biomaterials 2004;25:3569-82.
32. Ooms EM, Egglezios EA, Wolke JGC, Jansen JA. Soft tissue response to newly developed calcium phosphate cements. Biomaterials 2003;24:749-57.
33. Venien A, Levieux D. Differentiation of bovine from porcine gelatins using polyclonal anti-peptide antibodies in indirect and competitive indirect ELISA. J Pharm Biomed Anal 2005;39:418-24. (Pubitemid 41196044)
34. Liang HC, Chang WH, Lin KJ, Sung HW. Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration: in vitro and in vivo studies. J Biomed Mater Res A 2003;65(2):271-82.